Sponsored Links

Prana's Research Was Presented At International Conference On Alzheimer's Disease On July 14 PDF Print E-mail
Medical News - Alzheimer's and Dementia
Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), Head of Research, Assoc. Prof. Robert Cherny, presented new data on PBT2, the Company's lead compound in development for Alzheimer's Disease on July 14th at the prestigious International Conference of Alzheimer's Disease (ICAD) in Honolulu...

Read more: Alzheimer's / Dementia News From Medical News Today